Intergroup, I.M. (2025) “35 | Real-world outcomes of targeted therapy in stage IV melanoma after relapse on adjuvant dabrafenib and trametinib: insights from a single-center cohort: Rossella Villani, Chiara Bungaro, Anna Cecere, Ileana De Roma, Sabino Strippoli, Michele Guida | Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy”., Dermatology Reports [Preprint]. doi:10.4081/dr.2025.10777.